# Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)

> **NCT05903989** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 708 (actual)

## Conditions studied

- COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05903989
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-11
- **Primary completion:** 2023-10-24
- **Final completion:** 2023-10-24
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05903989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05903989, "Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05903989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*